Short CommunicationAspirin for the primary prevention of vascular events?
Section snippets
Ethical approval
None sought.
Funding
None declared.
Competing interests
None declared.
References (10)
Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials
Lancet
(2009)UK Comparative Audit of Upper Gastrointestinal Bleeding and the Use of Blood
(2007)- et al.
Age threshold for vascular prophylaxis by aspirin in patients without diabetes
Heart
(2008) - et al.
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?
PLoS Med
(2009) - et al.
Oxford Vascular Study. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study)
Lancet
(2005)
There are more references available in the full text version of this article.
Cited by (0)
Copyright © 2009 The Royal Society for Public Health. Published by Elsevier Ltd. All rights reserved.